Viewing Study NCT00540657


Ignite Creation Date: 2025-12-24 @ 6:42 PM
Ignite Modification Date: 2025-12-25 @ 4:12 PM
Study NCT ID: NCT00540657
Status: COMPLETED
Last Update Posted: 2025-03-06
First Post: 2007-10-05
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Phase II Study of CCX282-B in Patients With Celiac Disease
Sponsor: Amgen
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module